Image source: BlazeTV screenshot
© 2024 Blaze Media LLC. All rights reserved.
Researchers at Stanford University suggest that the lockdowns have been an overreaction. COVID-19 could be much more widespread and much less deadly than models originally predicted.
The Goal
Stanford set out to do the first random-sample antibody test for SARS-2 coronavirus In the United States. The study focused on areas most affected by the virus, so the worst-case scenarios.
The presence of antibodies suggests a person has had exposure to the virus, never was sick, or recovered and is now immune. Scientists believe it is highly unlikely a person be infected or reinfected if antibodies are present.
How soon Americans can return to our usual way of life depends on how widespread antibodies are currently.
Stanford found that between 2.46% and 4.16% of people it randomly sampled had SARS-2 coronavirus antibodies.
BlazeTV's Steve Deace broke down the numbers, and they are shocking.
Use code DEACE to save $30 on one year of BlazeTV.
Want more from Steve Deace?
To enjoy more of Steve's take on national politics, Christian worldview and principled conservatism with a snarky twist, subscribe to BlazeTV — the largest multi-platform network of voices who love America, defend the Constitution and live the American dream.
Update: This story has been corrected to note that Stanford found between 2.46 % and 4.16% of the people it sampled had the coronavirus antibodies.
Want to leave a tip?
We answer to you. Help keep our content free of advertisers and big tech censorship by leaving a tip today.
Want to join the conversation?
Already a subscriber?
News, opinion, and entertainment for people who love the American way of life.
BlazeTV
BlazeTV Staff
News, opinion, and entertainment for people who love the American way of life.
@BlazeTV →more stories
Sign up for the Blaze newsletter
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.
© 2024 Blaze Media LLC. All rights reserved.
Get the stories that matter most delivered directly to your inbox.
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.